Dr. David Ho: The AIDS pioneer shifts to COVID-19

FAN Editor

This week on 60 Minutes, correspondent Scott Pelley reports on the race to develop therapeutic drugs to reduce the severity of COVID-19. He speaks with Dr. David Ho, a virologist whose team at Columbia University is working around the clock on monoclonal antibodies. 

When patients have COVID-19, their immune systems develop antibodies to attack the virus. Doctors can harvest those antibodies, clone them, and reproduce them in the billions to help patients sick with the virus. One such patient was President Donald Trump, who was given a monoclonal antibody therapy from Regeneron Pharmaceuticals. 

It is not the first time Dr. Ho has worked on therapies to treat a high-profile virus with prominent patients — nor was it his first appearance on 60 Minutes. Prior to this year’s pandemic, his specialty was AIDS research. In the 1990s, he helped pioneer a revolutionary drug cocktail for treating AIDS, making the illness a manageable disease, rather than a death sentence. 

Former NBA legend Magic Johnson has become the living example of Dr. Ho’s work. In 1998, 60 Minutes correspondent Lesley Stahl interviewed Dr. Ho about Johnson, whom he has treated since Johnson’s diagnosis nearly 30 years ago. 

In Stahl’s report, Johnson’s wife, Cookie, said the turning point in her husband’s illness was nothing short of a miracle cure from God. 

But Dr. Ho insisted the treatment was not a miracle — and it wasn’t a cure: “I think there’s been a great deal of complacency just because of the progress that’s been made in treatment.” 

To watch Scott Pelley’s 60 Minutes report on COVID-19 therapeutics, click here.

© 2020 CBS Interactive Inc. All Rights Reserved.

Free America Network Articles

Leave a Reply

Next Post

60 Minutes goes inside the Lincoln Project

With the president now infected with the novel coronavirus, there isn’t much in this election year that can be described as “normal.” But among the most abnormal is that a group of lifelong Republicans — political strategists for Republican candidates for the last 30 years — have banded together to […]